When it comes to offering to pay clinical trial subjects to participate, the line between compensation and coercion is difficult to draw but all too easy to cross. Reimbursing participants for expenses incurred — travel, lodging, childcare — is…
Packaging Trends and the Future of the Generics Market in India
Around the world, the pharmaceutical market is rapidly evolving, driven by greater access to medicines, an increased focus on patient needs and the emergence of innovative therapies for chronic conditions such as diabetes, multiple sclerosis and rheumatoid arthritis. Industry analyst…
Novotech CRO strengthens South Korean Clinical Capabilities partnering with 2 Major Hospitals
Ulsan University Hospital (UHH) and Seoul National University Hospital (SNUH), Hepatology Division have joined the Novotech CRO partnership program SYDNEY, Apr 18, 2019 – (ACN Newswire) – Novotech, the award-winning Asia-Pacific CRO with 23 years of experience in the region,…
Development of biologics: The market requires short development times and high productivity
Biologics offer new therapy options for numerous diseases: They are already used to treat cancer and autoimmune diseases such as rheumatoid arthritis as useful alternatives to standard therapies. The extent of their market potential is revealed by the fact…
Pharm-Olam Wins 2019 CRO Leadership Awards
Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for oncology, infectious diseases and vaccines, and rare and orphan diseases, has been named a winner in Life Science Leader magazine’s 2019 CRO Leadership Awards. Pharm-Olam was rated highly by…
Top Academic Centers Flouting Trial Reporting Requirements, Report Shows
Top U.S. academic centers are routinely ignoring federal rules requiring them to report clinical trial data, a new analysis by a pair of nonprofit advocacy groups finds. Nearly one-third of the 450 university-based trials surveyed by Universities Allied for Essential…
Innovation in Investigator Site Contracting
In the perpetual pursuit of a more efficient clinical research process, biopharmaceutical sponsors and contract research organizations (CROs) have traditionally focused their resources on the more costly and time-consuming aspects of study start-up such as protocol development, regulatory and ethical…
Clinical Trials Are About Hope and Possibilities, Author and Trial Veteran Says
In 2011, Mary Elizabeth Williams was diagnosed with metastatic melanoma, a finding that usually means a patient has six to seven months to live. Knowing melanoma doesn’t respond well to traditional cancer treatments, she decided to take a chance on…
Intentional or Accidental, Bad Data Can Kill Trials and Careers
Two kinds of data integrity problems cast shade on research results and erode trust in scientific inquiry: questionable research practices and flat-out misconduct, a data integrity expert says. And while intentional misdeeds can result in regulatory, or even criminal, action,…
